• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Monday, October 13, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

How Next-Generation Sequencing Tech Can Advance Cancer Research — Experts

by Royal Ibeh and Leadership News
12 months ago
in Business
Cancer research
Share on WhatsAppShare on FacebookShare on XTelegram

In commemoration of Breast Cancer Awareness Month in October, experts have stressed the need for early detection through screening and targeted therapy upon diagnosis, saying these are keys to living breast cancer-free life.

Advertisement

This was disclosed at a workshop brought together to address the challenges and opportunities of precision oncology in Africa.

Organised by ISN Medical and Illumina, in collaboration with Covenant Applied Informatics and Communication-Africa Center of Excellence (CApIC-ACE) at Covenant University, the five-day workshop focused on ‘Personalising Cancer Care in Africa through Genomics’.

Advertisement

Attendees included policy makers, renowned scientists, researchers, and medical specialists, who deliberated on the advancement of Next-Generation Sequencing (NGS) technology to improve cancer diagnosis and treatment.

Key issues discussed included the importance of genetic diversity and inclusion in precision oncology, challenges and opportunities for precision oncology in Africa, protecting the African genome from exploitation, and enhancing capacity building in NGS technology.

The Centre Leader for CApIC-ACE, Professor Emeka Iweala, in his welcome speech, disclosed the mission of CApIC-ACE in precision oncology.

RELATED NEWS

Cardoso Reaffirms ‘Stability First, Then Growth’ Approach At London Business School Dialogue

Polaris Bank Wins Digital, MSME Awards For Fifth Consecutive Year

Oil & Gas Service Providers Back Dangote Refinery, Highlight Role In FX Market Stability

Recycling Firm cuts carbon emissions in Nigeria by 8,000 tonnes

He said: “Our focus is to discover and develop unique biomarkers for prostate and breast cancer that can be used for patient stratification and treatment selection in prostate cancer.”

Representing the Director General of the National Institute for Cancer Research and Treatment (NICRAT), Dr. Arisegi Sarafedeen Adeniyi, said that the institute was “poised to lead in the integration of genomics-based personalised treatment in our healthcare system, especially with the recent establishment of a genomic research unit and our collaboration with global genomic institutes.”

Participants commenting emphasised the need for collaborative approaches to precision oncology, highlighting the significance of including healthcare practitioners on the ongoing conversations and introducing genomics to the curriculum.

Speaking about the progress made so far in the country, Dr. Tolulope Adewole, the CEO of MedServe, NSIA-LUTH Cancer Centre, said that his team are participating in the first ever Phase 3 clinical trials in Sub-Saharan African and building more cancer centres and diagnostic centres across the country to enhance genomic studies for cancer care.

The workshop’s practical training component equipped laboratory representatives from various institutions, including the National Hospital, Abuja, Marcelle Ruth Cancer Center, Lakeshore Cancer Centre, and Institute of Human Virology Nigeria (IHVN), with hands-on experience in Illumina NGS platforms and bioinformatics analysis.

“This initiative demonstrates our commitment to advancing cancer care in Africa through precision medicine,” stated ISN Medical.

Boutros Maroun representing Illumina said, “we envision that the future of cancer care will involve various approaches including Comprehensive Genomic Profiling (CGP), diagnosing, monitoring cancer progression, and more clinical trials.”

The collaboration aims to promote better health outcomes and improved patient care by leveraging NGS-enabled precision oncology.

Join Our WhatsApp Channel

SendShare10176Tweet6360Share

OTHER NEWS UPDATES

Cardoso Reaffirms ‘Stability First, Then Growth’ Approach At London Business School Dialogue
Business

Cardoso Reaffirms ‘Stability First, Then Growth’ Approach At London Business School Dialogue

1 hour ago
Polaris Bank Steps Up Fight Against Breast Cancer With Free Screenings
Business

Polaris Bank Wins Digital, MSME Awards For Fifth Consecutive Year

10 hours ago
Dangote Refinery Receives 1 Million Barrels Of Crude Oil
Business

Oil & Gas Service Providers Back Dangote Refinery, Highlight Role In FX Market Stability

10 hours ago
Advertisement
Leadership join WhatsApp

LATEST UPDATE

Ex-Super Eagles Star Mutiu Adepoju Hails Daughter On Graduation From Aviation School In Belgium

4 minutes ago

Israel/Hamas: Make Peace With Bandits, Sheikh Gumi Tells Tinubu

38 minutes ago

CAN Mourns Renowned Televangelist Uma Ukpai, Describes Him As ‘Pillar Of Faith’

45 minutes ago

2024 Batch ‘C’ Stream I Corps Members To Pass Out Nov 6 — NYSC

57 minutes ago

Cardoso Reaffirms ‘Stability First, Then Growth’ Approach At London Business School Dialogue

1 hour ago
Load More

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.